EDIT - Company ID 0001650664
The table below shows Editas Medicine, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $181.81M | $123.65M | $165.65M | $138.54M | $138.69M | $95.83M |
| Short-term investments | $29.83M | - | $0.00 | $39.96M | $82.27M | $169.26M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $218.07M |
| $128.07M |
| $176.89M |
| $182.80M |
| $224.84M |
| $271.14M |
| Property, plant & equipment | $2.57M | $2.88M | $4.29M | $4.58M | $8.18M | $15.42M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $237.36M | $149.34M | $201.75M | $210.58M | $263.65M | $327.57M |
| Accounts payable | $4.74M | $4.33M | $3.16M | $6.72M | $5.46M | $12.49M |
| Total current liabilities | $68.43M | $39.78M | $61.77M | $65.94M | $73.11M | $72.35M |
| Long-term debt | $48.24M | $47.18M | $54.07M | $51.67M | $49.58M | - |
| Total liabilities | $132.08M | $144.93M | $188.30M | $191.39M | $201.23M | $151.93M |
| Retained earnings | -$1.67B | -$1.65B | -$1.62B | -$1.60B | -$1.54B | -$1.42B |
| Total equity | $105.28M | $4.41M | $13.45M | $19.19M | $62.42M | $175.63M |